ArticleThe American journal of drug and alcohol abuse2024
Pivoting from in-person to phone survey assessment of alcohol and substance use: effects on representativeness in a United States prospective cohort of women living with and without HIV.
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in The American journal of drug and alcohol abuse, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 23% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 12 institutions in 1 country.
Hannah R TierneySchool of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0001-8316-3451
Yifei MaDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-3326-0098
Peter BacchettiDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Adaora A AdimoraDivision of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Aruna ChandranDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Mirjam-Colette KempfSchools of Nursing, Medicine and Public Health Birmingham, University of Alabama at Birmingham, Birmingham, AL, USA.
Lauren F CollinsDivision of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Jack DeHovitzDepartment of Medicine, State University of New York-Downstate Medical Center, Brooklyn, NY, USA.
Ralph J DiClementeDepartment of Social and Behavioral Sciences, NYU School of Global Public Health, New York, NY, USA.
Audrey L FrenchDepartment of Medicine, Division of Infectious Diseases, Stroger Hospital of Cook County, Chicago, IL, USA.
Deborah L JonesDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Anjali SharmaDepartment of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Amanda B SpenceDivision of Infectious Diseases, Georgetown University Medical Center, Washington, DC, USA.
Judith A HahnDivision of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-2697-8264
Jennifer C PriceDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3825-5696
Phyllis C TienDepartment of Medicine, Department of Veteran Affairs Medical Center, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-3867-6770
University of California, San Francisco · USAlbert Einstein College of Medicine · USEmory University · USGeorgetown University · USJohn H. Stroger, Jr. Hospital of Cook County · USJohns Hopkins University · USNew York University · USSan Francisco VA Medical Center · USState University of New York · USUniversity of Alabama at Birmingham · USUniversity of Miami · USUniversity of North Carolina at Chapel Hill · US
Funding
UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1MVirology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1MEngaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0MVirology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9MVirology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0MQAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7MSF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bradley E Aouizerat, Jennifer Cohen Price · 2019 to 2026
$36.3MSex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosisU01HL146193 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Gange, Elizabeth Topper · 2019 to 2026
$35.8MUniversity of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8MSex differences in the role of multi-omics in HIV-associated carotid artery atherosclerosisU01HL146204 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI David B. Hanna, Anjali Sharma · 2019 to 2026
$33.2MUniversity of Pittsburgh MWCCS Clinical Research SiteU01HL146208 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bernard Jonas C Macatangay, CHARLES R RINALDO · 2019 to 2026
$32.2MMACS/WIHS Combined Cohort Study Clinical Research SiteU01HL146241 · NHLBI · EMORY UNIVERSITY · PI Cecile Delille Lahiri, Anandi Nayan Sheth · 2019 to 2026
$24.2MNCATS NIH HHS KL2 TR001432NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR003098NHLBI NIH HHS L30 HL159721NHLBI NIH HHS U01 HL146192NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01 HL146194NHLBI NIH HHS U01 HL146202NHLBI NIH HHS U01 HL146204NHLBI NIH HHS U01 HL146205NHLBI NIH HHS U01 HL146208NHLBI NIH HHS U01 HL146241NHLBI NIH HHS U01 HL146242NHLBI NIH HHS U01 HL146245NIAAA NIH HHS K24 AA022586NIAID NIH HHS K24 AI108516NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIA NIH HHS K23 AG084415NIA NIH HHS U54 AG062334NIMH NIH HHS P30 MH116867NIMH NIH HHS P30 MH133399
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19HIV InfectionsSubstance-Related DisordersFemaleHumansPandemicsProspective StudiesUnited Statesalcohol consumptionCOVID-19 pandemicHIVsubstance usesurvey methodswomen
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.